The companies piloted this in-pharmacy program last fall.

BOISE, Idaho — Cue Health and Albertsons Cos. announced Tuesday a first-of-its-kind partnership that offers customers access to Cue’s highly accurate, convenient, and fast molecular COVID-19 tests at participating Albertsons Cos. pharmacies across the country. Pharmacy personnel will provide this new service, which will allow customers to get Cue’s lab-quality COVID-19 test results delivered to their email in 20 minutes.

Albertsons Cos. and Cue piloted this in-pharmacy COVID-19 testing program last fall in 40 pharmacies in the state of Washington and at Lumen Field for fans attending Seattle Seahawks home games. The companies have since rolled out the offering into approximately 900 pharmacies and expect the test to be available at most Albertsons Cos. pharmacies over the coming weeks.

“This collaboration encapsulates what we believe is a critical component to the future of diagnostics: immediate access to convenient, fast, and highly accurate testing solutions on the go,” said Ayub Khattak, Co-founder and CEO of Cue Health. “Whether individuals require testing for travel, work, or peace of mind, in-pharmacy testing at Albertsons stores removes barriers and provides real-time data that enables customers to make more informed decisions. We are excited to work with Albertsons to offer more customers access to our innovative testing technology as we work to usher in the digital transformation of personalized healthcare.”

“To offer customers convenient, quick and accurate solutions we have partnered with Cue Health to feature these tests in our community pharmacies. Adding this diagnostic test expands options for our customers to access proactive health and wellness solutions at our stores,” said Omer Gajial, Albertsons Cos. EVP of Pharmacy and Health.

Customers can schedule a Cue test at an Albertsons Cos. pharmacy at www.scheduletest.com. Walk-ins and appointments are also available through the Albertsons Cos. local banner app for people ages 2 and over. Testing under the age of 18 requires parental consent and must have a guardian present.

As a nucleic acid amplification test (NAAT), Cue’s molecular COVID-19 test meets current testing entry requirements in many countries around the world, including international air travel into the U.S. and Canada, and the results are often accepted by employers, schools, and sports and entertainment venues.

Cue’s molecular COVID-19 test is known for its accuracy and has the distinct advantage of serving the needs of people with vision loss, who cannot as easily use the rapid antigen tests offered by the federal government’s free testing program.